Navigating the Liquid Biopsy Landscape and the Role of ctDNA in Lung Cancer Research

This webinar has now concluded.

ctDNA analysis holds significant promise in lung cancer management, offering opportunities for early detection, personalized treatment selection, and real-time monitoring of treatment response.

Despite its promise, several challenges and limitations remain in the clinical implementation of ctDNA analysis for lung cancer. These include issues related to sensitivity and specificity, detection of low-frequency mutations, standardization of methodologies, and cost-effectiveness. Addressing these challenges will be crucial for further advancing the utility of ctDNA analysis in routine clinical practice. In this webinar, we delved into the intricacies of analyzing ctDNA and other LBx biomarkers and explored strategies to overcome existing challenges, paving the way for its widespread adoption in clinical settings.

Webinar On Demand Available Soon